UBS Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.63M | Sell |
|
|||||
|
2025
Q2 | $7.43M | Buy |
|
|||||
|
2025
Q1 | $976K | Sell |
|
|||||
|
2024
Q4 | $21.7M | Buy |
|
|||||
|
2024
Q3 | $1.54M | Buy |
|
|||||
|
2024
Q2 | $1.06M | Sell |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $895K | Buy |
|
|||||
|
2023
Q3 | $305K | Buy |
|
|||||
|
2023
Q2 | $237K | Buy |
|
|||||
|
2023
Q1 | $240K | Buy |
|
|||||
|
2022
Q4 | $247K | Buy |
|
|||||
|
2022
Q3 | $186K | Sell |
|
|||||
|
2022
Q2 | $356K | Buy |
|
|||||
|
2022
Q1 | $173K | Sell |
|
|||||
|
2021
Q4 | $446K | Buy |
|
|||||
|
2021
Q3 | $83K | Buy |
|
|||||
|
2021
Q2 | $50K | Sell |
|
|||||
|
2021
Q1 | $628K | Sell |
|
|||||
|
2020
Q4 | $748K | Buy |
|
|||||
|
2020
Q3 | $206K | Sell |
|
|||||
|
2020
Q2 | $236K | Sell |
|
|||||
|
2020
Q1 | $199K | Buy |
|
|||||
|
2019
Q4 | $178K | Buy |
|
|||||
|
2019
Q3 | $51K | Buy |
|